INS and Alzheimer disease: Two new transgenic mouse models have been produced that demonstrate how AD pathology can exacerbate insulin signaling deficiencies and glucose tolerance and how diabetes can enhance cerebrovascular Aβ deposition and amyloid mediated vascular inflammation.